T he perception of pain from a given stimulus is influenced by numerous factors, including patient variability, ethnic background, socioeconomic class, previous life experiences and support systems. About 52% of patients report pain during burn wound debridement, whereas 84% describe extreme pain after therapeutic procedures. [1] [2] [3] Adequate analgesia and sedation are supposed to prevent stress-induced reactions such as hyper metabolism, sodium and water retention, hypertension, tachycardia and altered wound healing and to optimize patient comfort. [4, 5] If sedation is too deep it can have negative side-effects such as increased risk of pneumonia, venous thrombosis, bowel motility problems, hypotension and a prolonged stay in the ICU, resulting in increased costs. [6, 7] The requirements for ideal analgesia and sedation are the ability to sedate the patient deeply for necessary procedures, but with medication of short duration so that the patient can be quickly responsive and cooperative. Ostadalipour, et al.
Clonidine hydrochloride, an α 2 adrenoceptor agonist, is currently used for pre anaesthetic medication owing to its sedative and analgesic properties. [9] Unlike most other sedative drugs, α 2 adrenoceptor agonists are capable of producing sedation and analgesia and result in little, if any, respiratory change.
[10] It has been reported to decrease opioid dosage without affecting the quality of analgesia, [2] although clonidine has side-effects of hypotension and bradycardia.
[11] This combination makes them potentially useful in the postoperative, non ambulatory setting, considered the control group, received placebo (prepared in the Pharmacology Institute of Mazandaran University of Medical Science) with the same procedure. The placebo was prepared in the same size and color packages as clonidine tablets. The two groups were matched for age, sex and total body burn surface area.
All patients were fluid-resuscitated according to Parkland formula guidelines. Patients in the case group were tested with oral clonidine (0.1 mg) and blood pressure measured especially in high dependency and intensive care after one hour. If no hypotensive events occurred (decreases situations. With the development of the new α 2 -agonists, in blood pressure to <20% of baseline values), 0.1 mg there has been a resurgence of interest in the use of this clonidine TDS was administered on the first day followed class of drugs for sedation purposes. [12] [13] [14] [15] Unfortunately, by 3.3 µg/kg TDS on the second and third days. In both only a few studies have been done about the effectiveness groups, if any patient suffered from pain, a Cocktail drug of clonidine in managing burn patients. In this study we (containing pethidine 100 mg, promethazine 100 mg and conducted a clinical trial to evaluate the analgesic and chlorpromazine 100 mg in 14cc sterile water, 3cc per antisympathetic effects of clonidine in burn patients.
dose) was administered, according to patient requirement. Pain severity, heart rate and systolic blood pressure were MATERIALS AND METHODS recorded before and one hour after clonidine administration and during debridement. The severity of overall pain was 
Patients
One hundred patients with the American Society of Anesthesiologists physical status 1 and 2 who had suffered skin burns to approximately 30% of their body were admitted into the study. The patients ranged in age from 14 to 64 years. Patients were excluded from the study if they had severe systemic disease (e.g. renal failure, congestive heart failure) or sepsis, addiction, if they were pregnant or if they could not give informed consent.
Study procedures
Patients were divided equally and randomly assigned by lottery to two groups as following: Case group, the patients who received oral clonidine and the patients 27.60±11.4 years) were enrolled. The two groups of patients were similar with respect to demographic data and total body burn surface area [ Table 1 ].
The VAS pain scores in the clonidine group were significantly lower when compared with the placebo on the first, second ) .
Analgesic and antisympathetic effects of clonidine .0001 respectively). Pain severity in the case group was significantly lower than controls during debridement procedure (P=0.0001) on all days. Hemodynamic data obtained after drug administration revealed appreciably higher heart rates in the placebo group than in the group receiving clonidine, on the first, second and third days (P=0.001, P=0.001, P=0.0001 respectively). Systolic blood pressures were not appreciably different among the groups on the first and second days but on the third day a statistically significant difference between the two groups were observed (P=0.01) [ Table 2 ]. All the patients in both groups requested cocktail for analgesia. The number of cocktail requirements in the clonidine group were significantly lower than the controls on the first day (mean 1.96±0.6 vs. On the other hand, following the treatment with clonidine in the case group, the mean of VAS pain score, systolic blood pressure and heart rate decreased significantly compared with the prior treatment (P=0.0001) [ Figures 1-2 ].
DISCUSSION
Clonidine proved to be an effective drug to control blood presure and heart rate with a slight sedative effect that is desirable in the hemodynamic laboratory. Adequate analgesia and sedation for burn patients are important. [16] In addition to continuous burn pain, control of acute pain due to therapeutic procedures such as dressing changes and burn wound debridement is frequently necessary for such patients. Moreover, because skin incision for decompression and skin graft operation might be necessary for many burn patients, adequate analgesia is indispensable for postoperative patient care.
[11] Clonidine produces sedation and analgesia. [17] [18] [19] Our study demonstrated that clonidine can produce good, analgesia and decrease in sympathetic over-activity in burn patients and can also reduce opioid dose requirements. In this study a mild hypotension (about 9.7%) was observed, which is acceptable. A study by Lyons et al prospectively assessed the role of clonidine analgesic effects in a child with burns and they found that IV clonidine, dramatically reduced morphine consumption. [20] Although intravenous opioids, administered after gastrointestinal motility and constipation, nausea and
The use of continuous i.v. sedation is associated with prolongation vomiting, urinary retention and physical dependence. [2] of mechanical ventilation. Chest 1998;114:541-8. even high doses of opioids may not totally relieve the Assessment of clonidine orally disintegrating tablet for prepain in some patients. [21] Burn trauma elicits increased of organ blood flow. [22] The inhibition of post burn edema be secondary to increased vascular resistance and reduced 12. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, tissue perfusion pressure and/or suppressed inflammatory amnestic and analgesic properties of small-dose dexmedetomidine reaction in the burn injury. [23] In the treatment of burn ) .
